Insider Selling: Privia Health Group (NASDAQ:PRVA) CEO Sells $496,336.00 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 21,440 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $23.15, for a total value of $496,336.00. Following the sale, the chief executive officer directly owned 385,794 shares in the company, valued at approximately $8,931,131.10. This represents a 5.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Parth Mehrotra also recently made the following trade(s):

• On Tuesday, March 10th, Parth Mehrotra sold 21,097 shares of Privia Health Group stock. The stock was sold at an average price of $22.71, for a total value of $479,112.87.
• On Monday, March 9th, Parth Mehrotra sold 41,999 shares of Privia Health Group stock. The stock was sold at an average price of $22.86, for a total transaction of $960,097.14.

Privia Health Group Price Performance

PRVA stock opened at $21.73 on Friday. The firm has a market cap of $2.69 billion, a price-to-earnings ratio of 127.82, a PEG ratio of 1.39 and a beta of 0.82. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51. The firm has a fifty day moving average price of $22.93 and a two-hundred day moving average price of $23.58.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Thursday, February 26th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.21. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The company had revenue of $541.17 million for the quarter, compared to the consensus estimate of $516.61 million. During the same period last year, the firm posted $0.21 EPS. The company’s revenue for the quarter was up 17.4% on a year-over-year basis. As a group, analysts expect that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on PRVA shares. Jefferies Financial Group restated a “buy” rating and issued a $32.00 target price on shares of Privia Health Group in a research note on Thursday, February 26th. Truist Financial increased their price target on Privia Health Group from $31.00 to $33.00 and gave the stock a “buy” rating in a research report on Monday, March 2nd. Wolfe Research set a $31.00 price target on Privia Health Group in a report on Tuesday, January 6th. Royal Bank Of Canada started coverage on Privia Health Group in a research report on Friday, January 9th. They set an “outperform” rating and a $31.00 price objective for the company. Finally, Stephens restated an “overweight” rating and set a $32.00 price objective on shares of Privia Health Group in a research note on Thursday, December 4th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $31.00.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of Privia Health Group by 5.3% during the third quarter. Vanguard Group Inc. now owns 12,098,933 shares of the company’s stock valued at $301,263,000 after buying an additional 607,447 shares during the last quarter. Durable Capital Partners LP boosted its position in shares of Privia Health Group by 1.8% during the third quarter. Durable Capital Partners LP now owns 11,691,685 shares of the company’s stock worth $291,123,000 after buying an additional 203,842 shares during the period. State Street Corp grew its holdings in Privia Health Group by 1.5% in the 2nd quarter. State Street Corp now owns 4,171,069 shares of the company’s stock worth $95,935,000 after buying an additional 61,853 shares in the last quarter. Van Berkom & Associates Inc. increased its position in Privia Health Group by 1.8% in the 4th quarter. Van Berkom & Associates Inc. now owns 3,844,256 shares of the company’s stock valued at $91,147,000 after acquiring an additional 69,691 shares during the period. Finally, Geode Capital Management LLC increased its position in Privia Health Group by 1.1% in the 4th quarter. Geode Capital Management LLC now owns 2,814,290 shares of the company’s stock valued at $66,738,000 after acquiring an additional 31,204 shares during the period. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.